anti-ASIC antibodies (Regeneron Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-ASIC antibodies (Regeneron Pharmaceuticals)
Drug Alias NameREGN-AREGN-B
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAcid sensing Ion channels blockers
TargetsAcid sensing Ion channels
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A